Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07646847 · ClinicalTrials.gov registry record · NA

A Study of a Side Effects and Resource Navigation Program for People With Cancer

A NA study, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
NA
Development phase
200
Enrollment target

NCT07646847: Recruiting NA study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT07646847 is a NA study that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07646847, a NA study, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

The purpose of this study is to find out if the navigation program helps participants manage immunotherapy treatment better than usual care. Investigators will also look at how the navigation program impacts participants' quality of life. Investigators will measure quality of life by having participants complete questionnaires.

Interventions

  • OTHER Immunotherapy CARE Program

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2026-06-09
Est. Completion 2029-06-09
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT07646847

The ClinicalTrials.gov registry entry for NCT07646847 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Immunotherapy CARE Program is the first listed.

NCT07646847 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07646847 about?

NCT07646847 is a clinical study titled "A Study of a Side Effects and Resource Navigation Program for People With Cancer". The purpose of this study is to find out if the navigation program helps participants manage immunotherapy treatment better than usual care. Investigators will also look at how the navigation program impacts participants' quality of life. Investigators will measure quality of life by having particip...

What is the current status of trial NCT07646847?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-06-09. Estimated completion is 2029-06-09.

What interventions are being tested in trial NCT07646847?

The interventions under investigation include: Immunotherapy CARE Program (OTHER).

Who is sponsoring clinical trial NCT07646847?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.